Recurrent DKA results in high societal costs - a retrospective study identifying social predictors of recurrence for potential future intervention.

Lyerla, Ryan; Johnson-Rabbett, Brianna; Shakally, Almoutaz; Magar, Rekha; Alameddine, Hind; Fish, Lisa

Lyerla, Ryan; Johnson-Rabbett, Brianna; Shakally, Almoutaz; Magar, Rekha; Alameddine, Hind; Fish, Lisa.

Afiliação

Lyerla R; Allina Health, Minneapolis, MN, USA.
Johnson-Rabbett B; University of Nebraska Medical Center, Omaha, NE, USA.
Shakally A; Socal Endocrinology, Chino, CA, USA.
Magar R; HealthPartners, Anoka, MN, USA.
Alameddine H; Hennepin Health, Minneapolis, MN, USA. hind_alameddine@hotmail.com.
Fish L; Hennepin Health, Minneapolis, MN, USA.

Clin Diabetes Endocrinol ; 7(1): 13, 2021 Aug 01.

Article em En | MEDLINE | ID: mdl-34332631

Palavras-chave

Barriers to care; Insulin cost; Recurrent DKA

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Clin Diabetes Endocrinol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google